Home

Jenburkt Pharmaceuticals Ltd 52 Week High

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

YEARHIGH

₹ 1375

Last updated on: Feb 21, 2025

Key Highlights

  • The 52 Week HIGH of Jenburkt Pharmaceuticals Ltd is ₹ 1375 as of 21 Feb 25 .

Company Fundamentals for Jenburkt Pharmaceuticals Ltd

Market Price of Jenburkt Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20251004.3
20 Feb 20251023.25
19 Feb 20251019.4
18 Feb 2025966.7
17 Feb 20251017
14 Feb 20251029.05
13 Feb 20251095.25
12 Feb 20251069.85
11 Feb 20251056.8
10 Feb 20251089.45

Asset Value vs Market Value of Jenburkt Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Jenburkt Pharmaceuticals Ltd News Hub

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November

Read more

29 Oct 24

Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2

Read more

05 Nov 24

Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January

Read more

21 Jan 25

Jenburkt Pharmaceuticals standalone net profit rises 20.56% in the December 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 20

Read more

29 Jan 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Jenburkt Pharmaceuticals Ltd

What is the significance of Jenburkt Pharmaceuticals Ltd reaching its 52-week high?

Jenburkt Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Jenburkt Pharmaceuticals Ltd 52-week high?

Investors monitor Jenburkt Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Jenburkt Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Jenburkt Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Jenburkt Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Jenburkt Pharmaceuticals Ltd at its 52-week high?

Before investing in Jenburkt Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Jenburkt Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Jenburkt Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions